Accelerate Diagnostics ( (AXDXQ) ) has released a notification of late filing.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Accelerate Diagnostics, Inc. has filed a Form 12b-25, indicating a delay in submitting its Form 10-Q (Quarter Report) for the financial period ending June 30, 2025. The delay is primarily due to the company’s ongoing Chapter 11 bankruptcy proceedings and related asset sale activities, which have consumed significant resources and attention. The company has not provided a specific timeline for when the delayed report will be filed. Significant changes in financial results are expected due to adverse developments, including the bankruptcy and asset sale. The company is working on compliance efforts, with the notification signed by Jack Phillips, President and CEO.
Spark’s Take on AXDXQ Stock
According to Spark, TipRanks’ AI Analyst, AXDXQ is a Underperform.
The stock is severely impacted by financial distress, as evidenced by the Chapter 11 bankruptcy filing and ongoing losses. Technical analysis and valuation metrics further underscore the negative outlook, making this a high-risk investment.
To see Spark’s full report on AXDXQ stock, click here.
More about Accelerate Diagnostics
Average Trading Volume: 324,717
Technical Sentiment Signal: Strong Sell
Current Market Cap: $25
See more insights into AXDXQ stock on TipRanks’ Stock Analysis page.